JPMorgan Starts BioNTech (BNTX) at Overweight
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $86.80 +0.73%
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
JPMorgan analyst Cory Kasimov initiates coverage on BioNTech (NASDAQ: BNTX) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.52 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Resumes EQT Corp. (EQT) at Hold
- RBC Capital Starts Inspire Medical Systems (INSP) at Outperform
- Loop Capital Starts Instacart (CART) at Buy, 'Leading a Massive and Underpenetrated Category'
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
